Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

How Leptin Starts Signaling

Electron microscopy data reveal how metabolism-regulating hormone interacts with its receptor

by Carmen Drahl
October 29, 2012 | A version of this story appeared in Volume 90, Issue 44

[+]Enlarge
Credit: Adapted from Mol. Cell
This cartoon depicts how two copies of leptin (red, orange) lock two copies of the leptin receptor (dark green, aqua) in place, triggering signaling by Janus kinase (green).
This cartoon depicts how two copies of leptin (red, orange) lock two copies of the leptin receptor (dark green, aqua) into place, triggering signaling by Jak kinase (green).
Credit: Adapted from Mol. Cell
This cartoon depicts how two copies of leptin (red, orange) lock two copies of the leptin receptor (dark green, aqua) in place, triggering signaling by Janus kinase (green).

Using electron microscopy, researchers have amassed new insights about how the hormone leptin interacts with its receptor (Mol. Cell, DOI: 10.1016/j.molcel.2012.09.003). Signals from leptin, which is secreted by fat tissue, affect metabolism. This biochemical pathway has intrigued obesity drug researchers for more than a decade. But the arrangement of leptin’s signaling complex is in dispute, with camps proposing either a 2:2 or a 2:4 ratio of leptin to its receptor. Georgios Skiniotis and colleagues at the University of Michigan now provide strong evidence that the ratio is 2:2. They observed two copies of leptin that engaged two copies of the rod-shaped receptor, locking the floppy rods into place. They propose that this locking mechanism is key for signaling. The next step, Skiniotis says, will be to determine a structure of the complex that includes Janus kinase, an enzyme that mediates leptin signaling and is itself a drug target for cancer and immune disorders. Skiniotis adds that the mechanism of leptin signaling parallels that of related proteins, such as interleukin-6, which is implicated in cancer.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.